Jeon, Ok Hee https://orcid.org/0000-0002-3725-7526
Mehdipour, Melod
Gil, Tae-Hwan
Kang, Minha
Aguirre, Nicholas W.
Robinson, Zachery R.
Kato, Cameron https://orcid.org/0000-0002-8120-9345
Etienne, Jessy https://orcid.org/0000-0003-2173-6191
Lee, Hyo Gyeong
Alimirah, Fatouma
Walavalkar, Vighnesh
Desprez, Pierre-Yves
Conboy, Michael J. https://orcid.org/0000-0002-6434-4772
Campisi, Judith https://orcid.org/0000-0001-6858-9462
Conboy, Irina M.
Funding for this research was provided by:
Korea University (K2006261, K2025261)
National Research Foundation of Korea (2020R1C1C1009921)
the Glenn Foundation for Medical Research
U.S. Department of Health & Human Services | NIH | National Institute on Aging (T32 AG002266, R01 AG051729, P01 AG017242, R56 AG058819)
U.S. Department of Health & Human Services | National Institutes of Health (R56 AG052988 SA23061, R01 EB023776, R01 HL139605, R56 AG052988 SA23061)
the Pew Charitable Trust awarded to the Buck Institute for Research on Aging
- Open Philanthropy Foundation - QB3 Calico Award
Article History
Received: 2 July 2020
Accepted: 15 June 2022
First Online: 28 July 2022
Competing interests
: J.C. is a founder and shareholder of Unity Biotechnology, which develops senolytic drugs. All other authors declare no competing interests.